Order Article Reprints

Yao Y, Yang X, Li J, Guo E, Wang H, Sun C, Hong Z, Zhang X, Jia J, Wang R, et al. Preclinical Characterization of Efficacy and Pharmacodynamic Properties of Finotonlimab, a Humanized Anti-PD-1 Monoclonal Antibody. Pharmaceuticals. 2025; 18(3):395. https://doi.org/10.3390/ph18030395

Yao, Yunqi, Xiaoning Yang, Jing Li, Erhong Guo, Huiyu Wang, Chunyun Sun, Zhangyong Hong, Xiao Zhang, Jilei Jia, Rui Wang, and et al. 2025. "Preclinical Characterization of Efficacy and Pharmacodynamic Properties of Finotonlimab, a Humanized Anti-PD-1 Monoclonal Antibody" Pharmaceuticals 18, no. 3: 395. https://doi.org/10.3390/ph18030395

Yao, Y., Yang, X., Li, J., Guo, E., Wang, H., Sun, C., Hong, Z., Zhang, X., Jia, J., Wang, R., Ma, J., Dai, Y., Deng, M., Yu, C., Sun, L., & Xie, L. (2025). Preclinical Characterization of Efficacy and Pharmacodynamic Properties of Finotonlimab, a Humanized Anti-PD-1 Monoclonal Antibody. Pharmaceuticals, 18(3), 395. https://doi.org/10.3390/ph18030395